Tg Therapeutics (TGTX) Times Interest Earned (2011 - 2026)
Tg Therapeutics (TGTX) recorded quarterly Times Interest Earned of $4.54 in Q1 2026, down 41.28% quarter-over-quarter from $7.73 in Q4 2025, and up 255.71% on a YoY basis from $1.28 in Q1 2025.
Tg Therapeutics (TGTX) Times Interest Earned (2011 - 2026) Analysis & Trends
Tg Therapeutics' Times Interest Earned history runs 15 years deep, the most recent figure standing at $4.54 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 255.71% year-over-year to $4.54; the TTM figure through Mar 2026 stood at $5.41 (up 158.87% YoY), while the FY2025 annual figure was $4.61, up 164.42% from the prior year.
- Times Interest Earned was $4.54 for Q1 2026 at Tg Therapeutics, down from $7.73 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $30.91 in Q3 2023 to a low of -$27.09 in Q4 2022.
- Historically, Times Interest Earned has averaged -$3.92 across 5 years, with a median of $1.15 in 2024.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned slumped 96.29% in 2024, then jumped 280.62% in 2025.
- A 5-year view of Times Interest Earned shows it stood at -$27.09 in 2022, then soared by 53.88% to -$12.49 in 2023, then soared by 133.95% to $4.24 in 2024, then jumped by 82.23% to $7.73 in 2025, then sank by 41.28% to $4.54 in 2026.
- The last three Times Interest Earned figures came in at $4.54 (Q1 2026), $7.73 (Q4 2025), and $4.37 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Tg Therapeutics | 7.71 Bn | 7.06 Bn | 171.41 Mn | 4.54 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.54 |
| Dec 31, 2025 | 7.73 |
| Sep 30, 2025 | 4.37 |
| Jun 30, 2025 | 5.19 |
| Mar 31, 2025 | 1.28 |
| Dec 31, 2024 | 4.24 |
| Sep 30, 2024 | 1.15 |
| Jun 30, 2024 | 2.22 |
| Mar 31, 2024 | -4.05 |
| Dec 31, 2023 | -12.49 |
| Sep 30, 2023 | 30.91 |
| Jun 30, 2023 | -12.32 |
| Mar 31, 2023 | -13.01 |
| Dec 31, 2022 | -27.09 |
| Sep 30, 2022 | -21.22 |
| Jun 30, 2022 | -12.91 |
| Mar 31, 2022 | -25.10 |
| Dec 31, 2021 | -86.14 |
| Sep 30, 2021 | -82.01 |
| Jun 30, 2021 | -47.75 |